Synaptophysin-1 (SYNE1) as a Drug Target and Biomarker: A Journey Through Neurotransmission

Target Name: SYNE1

NCBI ID: G23345

SYNE1

Synaptophysin-1 (SYNE1) as a Drug Target and Biomarker: A Journey Through Neurotransmission

Introduction

Synaptophysin-1 (SYNE1) is a protein that plays a critical role in the structure and function of the synapse, the site of neurotransmitter release and reception in the nervous system. It is a small non-cysteine 鈥嬧?媝rotein that consists of 255 amino acids and has been identified as a potential drug target and biomarker for various neurological disorders. This article will explore the biology of SYNE1, its functions in neurotransmission, and its potential as a drug target.

The Importance of Synaptophysin-1

Synaptophysin-1 is a key protein that helps maintain the stability and integrity of the synapse, which is critical for the efficient transmission of neural signals. The synapse is the site where neurotransmitters, such as dopamine, serotonin, and endocannabinoids, are released and received , and the SYNE1 protein plays a critical role in regulating the release and reception of these molecules.

SYNE1 is expressed in various tissues and cell types, including the brain, where it is found in the postsynaptic terminal of neurons, and theCSC (cortical system), which is the part of the central nervous system responsible for the transmission of signals. It is involved in the regulation of neurotransmitter release and in the maintenance of the synapse, which is critical for the development and maintenance of normal brain function.

SYNE1 as a Drug Target

SYNE1 has been identified as a potential drug target due to its involvement in various neurological disorders, including Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders. The failure of neurotransmitter systems, such as dopamine and serotonin, can contribute to the development of these disorders..

SYNE1 has been shown to play a role in the regulation of neurotransmitter release and the maintenance of the synapse, which is thought to be a potential target for the development of neurodegenerative disorders. Several studies have shown that SYNE1 is involved in the regulation of dopamine release and that its expression is decreased in the brains of individuals with Alzheimer's disease.

SYNE1 has also been shown to play a role in the regulation of serotonin release and that its expression is decreased in the brains of individuals with Parkinson's disease. These findings suggest that SYNE1 may be a potential drug target for the development of neurodegenerative disorders.

SYNE1 as a Biomarker

SYNE1 has also been identified as a potential biomarker for various neurological disorders. The failure of neurotransmitter systems, such as dopamine and serotonin, can contribute to the development of these disorders, and the regulation of these systems by SYNE1 may be an important biomarker for these disorders.

SYNE1 has been shown to be involved in the regulation of neurotransmitter release and the maintenance of the synapse, which is critical for the development and maintenance of normal brain function. The regulation of neurotransmitter release by SYNE1 may be an important biomarker for the development and progression of various neurological disorders, including Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders.

Conclusion

SYNE1 is a protein that plays a critical role in the structure and function of the synapse, and its regulation of neurotransmission is involved in the development and maintenance of normal brain function. Its potential as a drug target and biomarker for various neurological disorders makes it an important area of 鈥嬧?媟esearch for the development of new treatments for these disorders. Further studies are needed to fully understand the role of SYNE1 in neurotransmission and its potential as a drug

Protein Name: Spectrin Repeat Containing Nuclear Envelope Protein 1

Functions: Multi-isomeric modular protein which forms a linking network between organelles and the actin cytoskeleton to maintain the subcellular spatial organization. As a component of the LINC (LInker of Nucleoskeleton and Cytoskeleton) complex involved in the connection between the nuclear lamina and the cytoskeleton. The nucleocytoplasmic interactions established by the LINC complex play an important role in the transmission of mechanical forces across the nuclear envelope and in nuclear movement and positioning. May be involved in nucleus-centrosome attachment and nuclear migration in neural progenitors implicating LINC complex association with SUN1/2 and probably association with cytoplasmic dynein-dynactin motor complexes; SYNE1 and SYNE2 may act redundantly. Required for centrosome migration to the apical cell surface during early ciliogenesis. May be involved in nuclear remodeling during sperm head formation in spermatogenesis; a probable SUN3:SYNE1/KASH1 LINC complex may tether spermatid nuclei to posterior cytoskeletal structures such as the manchette

The "SYNE1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SYNE1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets